P3 2L NSCLC Mono Comparator
Research payments
$3,239,329
Through program year 2024, $3,239,329 in research payments was reported against P3 2L NSCLC Mono Comparator, across 104 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $890,322 | 20 |
| 2023 | Research | $1,759,150 | 25 |
| 2022 | Research | $589,857 | 59 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
7 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Anjan Patel Sarasota, FL Named on 14 payments
- Viralkumar Bhanderi Tallahassee, FL Named on 6 payments
- Robert Jotte Lone Tree, CO Named on 5 payments
- Tony Ho Portland, OR Named on 5 payments
- Craig Reynolds Ocala, FL Named on 3 payments
- Kartik Konduri Dallas, TX Named on 3 payments
- David Waterhouse Cincinnati, OH Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.